Ventrus Could Start Pivotal Trial For Rx Hemorrhoid Therapy Mid-Year
This article was originally published in The Pink Sheet Daily
Executive Summary
The novel 5HT2a receptor antagonist would be the first FDA approved therapy for acute, non-surgical hemorrhoids, though intra-anal steroids are prescribed off-label for symptomatic relief.